COVID-19 Related Coagulopathy: A Distinct Entity?

Benjamin Marchandot Laurent SattlerLaurence JeselKensuke Matsushita Valérie B Schini-KerthLelia GrunebaumOlivier Morel

Published in: Journal of clinical medicine (2020)

The coronavirus disease 2019 (COVID-19) pandemic has impacted healthcare communities across the globe on an unprecedented scale. Patients have had diverse clinical outcomes, but those developing COVID-19-related coagulopathy have shown a disproportionately worse outcome. This narrative review summarizes current evidence regarding the epidemiology, clinical features, known and presumed pathophysiology-based models, and treatment guidance regarding COVID-19 coagulopathy.

Keyphrases

coronavirus disease
sars cov
healthcare
respiratory syndrome coronavirus
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
risk factors
patient reported
health information